Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease
- 1 May 1992
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 65 (5) , 766-768
- https://doi.org/10.1038/bjc.1992.161
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnoverJournal of Bone and Mineral Research, 1990
- Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseaseBone and Mineral, 1990
- Rapid assay for hard tissue collagen cross-links using isocratic ion-pair reversed-phase liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1989
- Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatographyAnalytical Biochemistry, 1988
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Calcium excretion (CaE) in metastatic breast cancerBritish Journal of Surgery, 1983
- [18] Urinary metabolites of collagenPublished by Elsevier ,1982
- The hydroxypyridinium crosslinks of skeletal collagens: Their measurement, properties and a proposed pathway of formationBiochemical and Biophysical Research Communications, 1980
- RELATION BETWEEN SERUM AND URINARY CALCIUM WITH PARTICULAR REFERENCE TO PARATHYROID ACTIVITYThe Lancet, 1969